| Discipline name | Position | Best Scientists | Publications | D-Index |
|---|---|---|---|---|
| Medicine | 959 | 73 | 114 | 24 |
Endocrine Pathology mainly deals with areas of study such as Pathology, Thyroid, Internal medicine, Immunohistochemistry and Endocrinology. Research on Pathology addressed in it frequently intersections with the field of Thyroid carcinoma. Endocrine Pathology addresses concerns in the field of Thyroid carcinoma by exploring it in line with topics in Cancer research which intersect with Mutation subjects.
It explores topics in Thyroid which can be helpful for research in disciplines like Malignancy and Radiology. It holds forums on Internal medicine that merges themes from other disciplines such as Gastroenterology and Oncology. The Immunohistochemistry works featured in it incorporate elements from Pheochromocytoma, Staining and Endocrine system.
Endocrine Pathology investigates Endocrinology research which frequently intersects with In situ hybridization. Pituitary adenoma research featured in Endocrine Pathology incorporates concerns from various other topics such as Acromegaly and Pituitary tumors. The study on Adenoma presented in the journal intersects with the topics under Pituitary neoplasm.
The journal papers explore disciplines such as Pathology, Thyroid, Immunohistochemistry, Thyroid carcinoma and Carcinoma. Pathology research in the journal publications connects with the study of Internal medicine. Issues in Thyroid were discussed in the most cited papers, taking into consideration concepts from other disciplines like Carcinogenesis and Follicular phase.
The main research concerns discussed in the journal are Pathology, Neuroendocrine tumors, Cancer research, Internal medicine and Thyroid carcinoma. Pathology studies presented in the journal focus on topics such as Immunohistochemistry, Carcinoma, Chromogranin A, Synaptophysin and Paraganglioma. While work presented in the journal provided substantial information on Immunohistochemistry, it also covered topics in Pheochromocytoma and Cellular differentiation.
While it focused on Internal medicine, it was also able to explore topics like Gastroenterology and Oncology. The Thyroid carcinoma study featured falls within the wider field of Thyroid. The subject of Malignancy, which is connected to the field of Fine-needle aspiration, serves as the foundation of the Thyroid research featured in the journal.
A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.
The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.
The top authors publishing in Endocrine Pathology (based on the number of publications) are:
The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.
Only papers with recognized affiliations are considered
The top affiliations publishing in Endocrine Pathology (based on the number of publications) are:
The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.
The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.
The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.
During the most recent 2021 edition, 6.25% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 48.89% were posted by at least one author from the top 10 institutions publishing in the journal. Another 11.11% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 24.44% of all publications and 15.56% were from other institutions.
A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.
The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.
The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.
Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).
The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:
The chart below illustrates experience levels of first authors in cases of publications with multiple authors.
A career in Endocrine Pathology requires extensive study and training. More often than not, this usually involves obtaining a degree in medicine, followed by specialized training in pathology and further sub-specialization in endocrine pathology. The career pathway can be diverse and rewarding, with opportunities in research, diagnostics, and academia.
Often, one might wonder about additional career pathways in healthcare that could complement an endocrine pathologist's role. One such pathway is that of a nurse practitioner, who can play a crucial role in managing patients with endocrine conditions alongside an endocrine pathologist. If you are in West Virginia and looking at options to become a nurse practitioner, we have a detailed guide on this. Check out our guide on how to be a nurse practitioner in West Virginia.
Beyond being a complementing role, pursuing a career as a nurse practitioner opens up opportunities for patient interactions, patient education, and a chance to play a more direct role in patient care.
If you are a researcher in endocrine pathology and are keen on diversifying your career or want to explore roles where you can have a direct impact on patient care, considering nursing pathways might be an interesting choice for you.
Marco Volante;Alfred K Lam;Mauro Papotti;Giovanni Tallini
(2021)Silvia Uccella;Stefano La Rosa;Jasna Metovic;Deborah Marchiori
(2021)C. Christofer Juhlin;C. Christofer Juhlin;Jérôme Bertherat;Thomas J. Giordano;Gary D. Hammer
(2021)Exploring a career in medicine often involves considering various educational routes and specialties. For those interested in nursing, online bsn programs offer an affordable way to advance from a Bachelor of Science in Nursing to a Master's degree, providing access to higher-level roles in healthcare.
If you're a registered nurse looking to enhance your qualifications, the best online rn to bsn programs can be completed without clinical hours, allowing greater flexibility and faster completion times for busy professionals.
For advanced practice nurses, pursuing a Doctor of Nursing Practice degree can elevate your career. Some institutions offer short dnp programs online, making it easier to earn your doctorate on a condensed schedule.
Not everyone seeks a long academic path initially. For those aiming to enter healthcare quickly, accelerated medical assistant programs provide a valuable entry point, enabling you to start working in as little as six weeks.
